This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 1999
Title: The Innovations of Harald Schlebusch
Introduction
Harald Schlebusch is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of monoclonal antibodies. His work has implications for cancer diagnostics and treatment.
Latest Patents
One of Harald Schlebusch's key patents is for monoclonal anti-idiotypic anti-CA125 antibodies and pharmaceutical applications. This patent represents a significant advancement in the detection and treatment of ovarian cancer, showcasing his innovative approach to medical science. He holds 1 patent in this area.
Career Highlights
Throughout his career, Harald has focused on the intersection of immunology and oncology. His research has contributed to a better understanding of cancer biomarkers, which is crucial for early detection and personalized treatment strategies. His dedication to advancing medical science is evident in his work.
Collaborations
Harald has collaborated with various professionals in the field, including his coworker Uwe Wagner. These partnerships have enhanced the scope and impact of his research, leading to more comprehensive solutions in cancer treatment.
Conclusion
Harald Schlebusch's contributions to the field of pharmaceuticals, particularly through his patent on monoclonal antibodies, highlight his role as an innovator in medical science. His work continues to influence cancer diagnostics and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile